369 filings
Page 13 of 19
4
dfw tb1hgo8wevyt
24 Jan 22
eFFECTOR Therapeutics / STEPHEN T WORLAND ownership change
8:04pm
424B3
lb53k 1hu
24 Jan 22
Prospectus supplement
4:21pm
8-K
3jpnfjxjvo3j4um he
24 Jan 22
Entry into a Material Definitive Agreement
4:12pm
4/A
xc9625 xe
17 Dec 21
eFFECTOR Therapeutics / Brian M. Jr. Gallagher ownership change
4:31pm
4
qi2tzctpgkket4 51
17 Dec 21
Change in insider ownership
4:30pm
4
ameqx2bz0wudoz lq
6 Dec 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
7:28pm
4
234 1bij93ac
6 Dec 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
7:27pm
4
djbe v4236u2t4iy
1 Dec 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
6:31pm
4
3yw0bc8xi0rqkf
1 Dec 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
6:31pm
4
dztwkfpdb7ee590z4pb9
26 Nov 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
4:44pm
4
m2wxhzt w5c7
26 Nov 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
4:43pm
4
m87 pd7jagl2vaf5
22 Nov 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
7:13pm
4
jfmyopw
22 Nov 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
7:12pm
4
dzla5ry5
17 Nov 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
7:56pm
4
6m3v 34i1uoptjsq4x
17 Nov 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
7:55pm
4
tctx8py3c
12 Nov 21
eFFECTOR Therapeutics / JONATHAN D ROOT ownership change
5:53pm
4
2wt1i gh4
12 Nov 21
eFFECTOR Therapeutics / Casey M Tansey ownership change
5:52pm
424B3
lbtpv4zvw5gt1ab7eqe6
8 Nov 21
Prospectus supplement
4:24pm
8-K
ezrkm63wy1o28qk 0z
8 Nov 21
Selected recommended Phase 2 dose (RP2D) of zotatifin for continued development for patients with certain solid tumors
7:05am